Current portfolio

Hutchmed

Among the first global-focused novel drug discovery companies in China

HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.

  • Healthcare
  • Greater China
  • The Baring Asia Private Equity Fund VII
  • 2021
Logo
0
EQT logo